Implementing a chatbot to promote hereditary breast & ovarian cancer genetic screening in women’s health: identifying barriers and facilitators to screening adoption
While chatbots can extend women's cancer risk screening access, particularly in rural regions and with college-educated women, systems-level (cost) and individual-level factors (perceived risk, misconceptions about repeating genetic testing) should be addressed to promote adoption. Women's interaction with a clinician may be a key implementation strategy for addressing these factors to personalize the screening opportunity and promote their chatbot screening adoption.
Authors
- Luisel Ricks‐Santi (ORCID: https://orcid.org/0000-0003-2987-9509)
- Elizabeth M. Eddy
- Easton N. Wollney (ORCID: https://orcid.org/0000-0003-2981-8060)
- Shireen Madani Sims (ORCID: https://orcid.org/0000-0003-0107-9163)
- Carla L. Fisher (ORCID: https://orcid.org/0000-0003-3903-4278)
- Daniel Wiesman
Institutions
- University of Florida (US)
- Old Dominion University (US)
- Florida College (US)
Publication Details
- Journal
- BMC Public Health
- Published
- 2025-07-19
- DOI
- https://doi.org/10.1186/s12889-025-23488-4
- Citations
- 1
- Primary Topic
- BRCA gene mutations in cancer
- Type
- article
- Field-Weighted Citation Impact
- 1.82
Funders
- National Institutes of Health
- Clinical and Translational Science Institute, University of Florida
- National Center for Advancing Translational Sciences